WV MSSP 2016
Location
Location
Aledade West Virginia ACO, LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
| ACO Participants | ACO Participant in Joint Venture |
| Charleston Internal Medicine Inc | N |
| Chesapeake Medical Center, PLLC | N |
| COMPREHENSIVE HEALTH SOLUTIONS, PLLC | N |
| DUNBAR MEDICAL ASSOCIATES PLLC | N |
| Family Health Associates of the Kanawha Valley PLLC | N |
| Finbar Powderly | N |
| Healthy Habits Wellness Ctr, Inc | N |
| JOHN HOLLOWAY | N |
| Kanawha Medical Center Inc | N |
| Mountain State Medicine and Rheumatology PLLC | N |
| Patel Inc | N |
| Prestige Primary Care Associates PLLC | N |
| Spring Hill Primary Care Physicians PLLC | N |
| Williamson Health & Wellness Center Inc | N |
| WV Primary Care Inc | N |
| Member Last Name | Member First Name | Member Title/Position | Member's Voting Power (Expressed as a percentage or number) | Membership Type | ACO Participant Legal Business Name and D/B/A, if applicable |
| Bowden | Thomas | Voting Member | 1 | ACO Participant Representative | Charleston Internal Medicine Inc |
| Bacha | Ghali | Voting Member | 1 | ACO Participant Representative | Chesapeake Medical Center, PLLC |
| Beckett | Donnovan | Voting Member | 1 | ACO Participant Representative | COMPREHENSIVE HEALTH SOLUTIONS, PLLC |
| Lilly | John | Voting Member | 1 | ACO Participant Representative | DUNBAR MEDICAL ASSOCIATES PLLC |
| DeTemple | Julie | Voting Member | 1 | ACO Participant Representative | Family Health Associates of the Kanawha Valley PLLC |
| Powderly | Finbar Gerard | Voting Member | 1 | ACO Participant Representative | Finbar Powderly |
| Miller | John | Voting Member | 1 | ACO Participant Representative | Healthy Habits Wellness Ctr, Inc |
| Holloway | John | Voting Member | 1 | ACO Participant Representative | JOHN HOLLOWAY |
| Jagannath | Thopsie | Voting Member | 1 | ACO Participant Representative | Kanawha Medical Center Inc |
| Triplett | Reginald | Voting Member | 1 | ACO Participant Representative | Mountain State Medicine and Rheumatology PLLC |
| Wilshere | John | Voting Member | 1 | Medicare Beneficiary Representative | N/A |
| Patel | Rohit | Voting Member | 1 | ACO Participant Representative | Patel Inc |
| Moore | Franklin | Voting Member | 1 | ACO Participant Representative | Prestige Primary Care Associates PLLC |
| Skaggs | Christopher | Voting Member | 1 | ACO Participant Representative | Spring Hill Primary Care Physicians PLLC |
| Johnson | Vickie | Voting Member | 1 | ACO Participant Representative | Williamson Health & Wellness Center Inc |
| Sheth | Ashish | Voting Member | 1 | ACO Participant Representative | WV Primary Care Inc |
| Wagner | Colleen | Voting Member | 1 | Other | N/A |
- Executive Director: Ms. Colleen Wanger
- Medical Director: Dr. Jonathan Lilly
- Compliance Officer: Ms. Sarah Chasson
- Quality Assurance/Improvement Officer: Dr. Emily Maxson
- Beneficiary Engagement Committee: Dr. Jonathan Lilly, Chair
- Transitions of Care Committee: Dr. Franklin Moore, Chair
- Compliance Committee: Dr. Jonathan Lilly
- Evidence-Based Medicine Committee: Dr. Christopher Skaggs Chair
- Networks of individual practices of ACO professionals
Second Agreement Period
- Performance Year 2019, $4,866,915
First Agreement Period
- Performance Year 2019, $4,866,915
- Performance Year 2018, $1,187,169
- Performance Year 2017, $2,950,672
- Performance Year 2016, $1,566,654
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2018
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2017
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2016
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
2019 Quality Performance Results
ACO#
Measure Name
Rate
ACO Mean
ACO-1
CAHPS: Getting Timely Care, Appointments, and Information
92.01
85.86
ACO-2
CAHPS: How Well Your Providers Communicate
96.42
94.11
ACO-3
CAHPS: Patients’ Rating of Provider
94.97
92.69
ACO-4
CAHPS: Access to Specialists
81.34
81.54
ACO-5
CAHPS: Health Promotion and Education
64.58
60.44
ACO-6
CAHPS: Shared Decision Making
65.42
62.78
ACO-7
CAHPS: Health Status/Functional Status
69.78
73.79
ACO-34
CAHPS: Stewardship of Patient Resources
29.68
26.17
ACO-45
CAHPS: Courteous and Helpful Office Staff
94.20
92.84
ACO-46
CAHPS: Care Coordination
88.54
86.89
ACO-8
Risk Standardized, All Condition Readmission
14.98
14.86
ACO-38
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions
54.78
58.15
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
1.94
1.87
ACO-13
Falls: Screening for Future Fall Risk
88.25
84.04
ACO-14
Preventive Care and Screening: Influenza Immunization
69.10
74.77
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
92.98
78.04
ACO-18
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan
88.54
70.40
ACO-19
Colorectal Cancer Screening
80.82
70.76
ACO-20
Breast Cancer Screening
78.44
73.84
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
82.66
82.17
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
13.29
13.88
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
70.06
75.04
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to the low sample size.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.
Payment Rule Waivers